US 11236329
Compound and method for treating myotonic dystrophy
granted A61KA61K31/7088A61K47/64
Quick answer
US patent 11236329 (Compound and method for treating myotonic dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/7088, A61K47/64, A61P, A61P21/00